Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of articledeveloping erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery.
Falvo E, Strigari L, Citro G, Giordano C, Arcangeli S, Soriani A, D'Alessio D, Muti P, Blandino G, Sperduti I, Pinnarò P. Falvo E, et al. Among authors: arcangeli s. BMC Cancer. 2011 Jul 12;11:291. doi: 10.1186/1471-2407-11-291. BMC Cancer. 2011. PMID: 21749698 Free PMC article. Clinical Trial.
Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO).
Maddalo M, Bonomo P, Belgioia L, Bacigalupo A, Donato V, Alterio D, Orlandi E, Argenone A, Merlotti A, Musio D, Trignani M, Ursino S, Arcangeli S, Furlan C, Osti MF; Italian Association of Radiation Oncology (AIRO). Maddalo M, et al. Among authors: arcangeli s. Eur Arch Otorhinolaryngol. 2018 Feb;275(2):561-567. doi: 10.1007/s00405-017-4853-8. Epub 2017 Dec 26. Eur Arch Otorhinolaryngol. 2018. PMID: 29279949
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?
Alongi F, Arcangeli S, Ramella S, Giaj-Levra N, Borghetti P, D'angelillo R, Ricchetti F, Maddalo M, Mazzola R, Trovò M, Russi E, Magrini SM; on the behalf of Associazione Italiana Radioterapia Oncologica (AIRO). Alongi F, et al. Among authors: arcangeli s. Expert Rev Anticancer Ther. 2017 Feb;17(2):157-165. doi: 10.1080/14737140.2017.1273111. Epub 2017 Jan 5. Expert Rev Anticancer Ther. 2017. PMID: 27984919 Review.
Moderate hypofractionation for prostate cancer.
Arcangeli S, Arcangeli G. Arcangeli S, et al. Among authors: arcangeli g. Oncotarget. 2017 Sep 29;8(49):84612-84613. doi: 10.18632/oncotarget.21386. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156657 Free PMC article. No abstract available.
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer.
Arcangeli G, Saracino B, Gomellini S, Petrongari MG, Arcangeli S, Sentinelli S, Marzi S, Landoni V, Fowler J, Strigari L. Arcangeli G, et al. Among authors: arcangeli s. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):11-8. doi: 10.1016/j.ijrobp.2009.07.1691. Epub 2010 Jan 4. Int J Radiat Oncol Biol Phys. 2010. PMID: 20047800 Clinical Trial.
Dose and volume as predictive factors of pulmonary toxicity.
Trodella L, Ramella S, Salvi G, Arcangeli S, Ciresa M, Massaccesi M, Macchia G, D'Angelillo RM. Trodella L, et al. Among authors: arcangeli s. Rays. 2005 Apr-Jun;30(2):175-80. Rays. 2005. PMID: 16294911 Review.
163 results